The review delved into the various mechanisms of action of curcumin in AD, encompassing its role in inhibiting Aβ and tau proteins, its capacity to bind copper, lower cholesterol levels, serve as an anti-inflammatory agent, modulate microglia, inhibit AChE, and function as an antioxidant. This evidence concerns the gene MAPT and Alzheimer disease.